title: Pathology, clinical presentations, and outcomes of C1q nephropathy.
abstract: C1q nephropathy is an uncommon glomerular disease with characteristic features on immunofluorescence microscopy. In this report, clinicopathologic correlations and outcomes are presented for 72 patients with C1q nephropathy. The study comprised 82 kidney biopsies from 28 children and 54 adults with male preponderance (68%). Immunofluorescence microscopy showed dominant or co-dominant staining for C1q in the mesangium and occasional glomerular capillary walls. Electron-dense deposits were observed in 48 of 53 cases. Light microscopy revealed no lesions (n = 27), focal segmental glomerulosclerosis (FSGS; n = 11), proliferative glomerulonephritis (n = 20), or various other lesions (n = 14). Clinical presentations in the patients who had no lesions histology were normal urine examination (7%), asymptomatic hematuria and/or proteinuria (22%), and nephrotic syndrome (minimal change-like lesion; 63%), which frequently relapsed. All patients with FSGS presented with nephrotic syndrome. Those with proliferative glomerulonephritis usually presented with chronic kidney disease (75%) or asymptomatic urine abnormalities (20%). Of the patients with sufficient follow-up data, complete remission of the nephrotic syndrome occurred in 77% of those with a minimal change-like lesion, progression to end-stage renal disease occurred in 33% of those with FSGS, and renal disease remained stable in 57% of those with proliferative glomerulonephritis. In conclusion, this study identified two predominant clinicopathologic subsets of C1q nephropathy: (1) Podocytopathy with a minimal change-like lesion or FSGS, which typically presents with nephrotic syndrome, and (2) a typical immune complex-mediated glomerular disease that varies from no glomerular lesions to diverse forms of glomerular proliferation, which typically presents as chronic kidney disease. Clinical presentation, histology, outcomes, and presumably pathogenesis of C1q nephropathy are heterogeneous.
authors.affiliation: Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia. alenka.vizjak@mf.uni-lj.si
authors.forename: Alenka
authors.initials: A
authors.lastname: Vizjak
authors.forename: Dusan
authors.initials: D
authors.lastname: Ferluga
authors.forename: Mojca
authors.initials: M
authors.lastname: Rozic
authors.forename: Anastazija
authors.initials: A
authors.lastname: Hvala
authors.forename: Jelka
authors.initials: J
authors.lastname: Lindic
authors.forename: Tanja Kersnik
authors.initials: TK
authors.lastname: Levart
authors.forename: Vesna
authors.initials: V
authors.lastname: Jurcić
authors.forename: J Charles
authors.initials: JC
authors.lastname: Jennette
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D015922:Complement C1q / Q000378:metabolism*; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000276:immunology / Q000473:pathology; D005923:Glomerulosclerosis, Focal Segmental / Q000276:immunology / Q000473:pathology; D006801:Humans; D007674:Kidney Diseases / Q000276:immunology* / Q000473:pathology*; D008297:Male; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D009402:Nephrosis, Lipoid / Q000276:immunology / Q000473:pathology; D009404:Nephrotic Syndrome / Q000276:immunology / Q000473:pathology; D011379:Prognosis
chemical_list: D015922:Complement C1q